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Summary
Abull aged16 months with bilateral testicular hypoplasia and azoospermiawas persistently infected with bovine
viral diarrhoea virus (BVDV).Viral antigen was detected in serum and semen by ELISA, but the animal was
serologically negative. After slaughter, the genital tract was examined histopathologically and by immunohisto-
chemistry, including double immunolabelling with BVDVantibody and either S-100 antibody (for Sertoli cells) or
ferritin antibody (for Leydig cells). The seminiferous tubules of both testes were lined by a single layer of Sertoli
cells and the germinal epitheliumwas completely absent except for a few remaining spermatogonia. BVDVanti-
genwas demonstrated (1) in themedia of arterial vessel walls of the testis, epididymis, urethra, prostate, and vesi-
cular and bulbourethral glands, (2) in epithelial cells of the ductus epididymidis, the accessory glands and the
urethra, and (3) in the testis, mainly in Sertoli cells and to a lesser extent in the spermatogonia that remained,
but not in Leydig cells.The testicular hypoplasiawas possibly linked to the BVDV infection.
r 2007 Elsevier Ltd. All rights reserved.
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Introduction
Bovine viral diarrhoeavirus (BVDV) is endemic in the
Swiss cattle population (Siegwart et al., 2006) and is as-
sociated with marked economic losses due to the need
for repeated breeding in cows, abortion, congenital
malformation, birth of weak and undersized calves
and persistently infected (PI) o¡spring (Shin and Ac-
land, 2001; Grooms, 2004). Congenital anomalies and
teratogenic e¡ects associated with BVDV include cere-
bellar hypoplasia, microencephalopathy, hydrocepha-
lus, hydranencephaly, porencephaly, hypomyelination,
cataracts, micro-ophthalmia, retinal degeneration, op-
tic neuritis, thymic hypoplasia, hypotrichosis/alopecia,
abnormal osteogenesis, mandibular brachygnathism,
growth retardation, curly hair coat, and hyena disease
(Grooms, 2004). BVDV is spread mainly via PI cattle
(Liess, 1988). Furthermore, Kirkland et al. (1994)
showed that semen collected from PIbulls was a poten-
tial source of BVDV infection for clean herds. BVDV
can produce acute infection, persistent infection, or
persistent localized testicular infection in bulls (Mey-
ling andJensen,1988; Kirkland et al.,1991; Givens et al.,
2003b). Insemination of sero-negative cowswith semen
from PI bulls may cause transient infection in dams
and frequently a¡ects herd fertility (Meyling and Jen-
sen,1988; Kirkland et al., 1991). Therefore, screening of
semen for BVDV is recommended before bulls enter an
arti¢cial insemination (AI) centre (Meyling and Jen-
sen,1988).
Barlow et al. (1986) described a PI bull in which
BVDV was isolated from blood, semen and testis; the
semen was of acceptable quality, but some degenera-
tion of seminiferous tubules was reported.The present
report describes a PI bull with testicular hypoplasia
and the precise distribution of BVDV antigen within
the male genital tract as demonstrated by single and
double immunohistochemical labelling.
www.elsevier.com/locate/jcpa
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Abstract
Chlamydiae cause abortion and reproductive disorders in sows. Although organisms can infect the male genital tract, little is
known about the disease situation in boars. Hence, we examined the prevalence of chlamydial infection in semen and genital
tracts of boars. Samples collected from Swiss boars (group A: n = 42), and boars from Germany (group B: n = 39) were
examined by bacteriology, LPS-ELISA, immunohistochemistry (IHC) and polymerase chain reaction (PCR). The latter
methodology involved use of three PCR assays including 16Sig rDNA, IGS-S (intergenic spacer 16S/23S-Short) and IGS-
L (intergenic spacer 16S/23S-Long) PCR for comparison methods. PCR sensitivity and the presence of potential PCR inhibitors
were determined by spiking semen with Chlamydophila (Cp.) abortusDNA. Detection limits of the 16Sig and IGS-S PCR were
10 templates, while the IGS-L PCR was less sensitive (100 templates). Of 25 semen samples that were collected from group A,
one semen sample was positive for Cp. psittaci and twowere positive for Chlamydia-like organisms by 16Sig PCR. Screening of
sera from Swiss boars revealed three animals with positive reactions in the LPS-ELISA, although we failed to detect chlamydiae
within organs of these or sera-negative animals by IHC or IGS-S PCR. In group B, 10 ejaculates were positive for Chlamydia
(C.) suis and two were positive for Chlamydia-like organisms by 16S PCR. The identification of DNA from Chlamydia-like
organisms in semen from both groups of boars was surprising and a role for these bacteria in reproductive diseases requires
further assessment. In conclusion, the prevalence of chlamydial infection was low in group A animals indicating that venereal
transmission may not be significant for Chlamydia-associated reproductive diseases in pigs, although rare cases may occur.
# 2006 Elsevier B.V. All rights reserved.
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1. Introduction
Chlamydial infections in pigs are associated with a
variety of clinical disorders including respiratory
www.elsevier.com/locate/vetmic
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Summary
Abull aged16 months with bilateral testicular hypoplasia and azoospermiawas persistently infected with bovine
viral diarrhoea virus (BVDV).Viral antigen was detected in serum and semen by ELISA, but the animal was
serologically negative. After slaughter, the genital tract was examined histopathologically and by immunohisto-
chemistry, including double immunolabelling with BVDVantibody and either S-100 antibody (for Sertoli cells) or
ferritin antibody (for Leydig cells). The seminiferous tubules of both testes were lined by a single layer of Sertoli
cells and the germinal epitheliumwas completely absent except for a few remaining spermatogonia. BVDVanti-
genwas demonstrated (1) in themedia of arterial vessel walls of the testis, epididymis, urethra, prostate, and vesi-
cular and bulbourethral glands, (2) in epithelial cells of the ductus epididymidis, the accessory glands and the
urethra, and (3) in the testis, mainly in Sertoli cells and to a lesser extent in the spermatogonia that remained,
but not in Leydig cells.The testicular hypoplasiawas possibly linked to the BVDV infection.
r 2007 Elsevier Ltd. All rights reserved.
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Introduction
Bovine viral diarrhoeavirus (BVDV) is endemic in the
Swiss cattle population (Siegwart et al., 2006) and is as-
sociated with marked economic losses due to the need
for repeated breeding in cows, abortion, congenital
malformation, birth of weak and undersized calves
and persistently infected (PI) o¡spring (Shin and Ac-
land, 2001; Grooms, 2004). Congenital anomalies and
teratogenic e¡ects associated with BVDV include cere-
bellar hypoplasia, microencephalopathy, hydrocepha-
lus, hydranencephaly, porencephaly, hypomyelination,
cataracts, micro-ophthalmia, retinal degeneration, op-
tic neuritis, thymic hypoplasia, hypotrichosis/alopecia,
abnormal osteogenesis, mandibular brachygnathism,
growth retardation, curly hair coat, and hyena disease
(Grooms, 2004). BVDV is spread mainly via PI cattle
(Liess, 1988). Furthermore, Kirkland et al. (1994)
showed that semen collected from PIbulls was a poten-
tial source of BVDV infection for clean herds. BVDV
can produce acute infection, persistent infection, or
persistent localized testicular infection in bulls (Mey-
ling andJensen,1988; Kirkland et al.,1991; Givens et al.,
2003b). Insemination of sero-negative cowswith semen
from PI bulls may cause transient infection in dams
and frequently a¡ects herd fertility (Meyling and Jen-
sen,1988; Kirkland et al., 1991). Therefore, screening of
semen for BVDV is recommended before bulls enter an
arti¢cial insemination (AI) centre (Meyling and Jen-
sen,1988).
Barlow et al. (1986) described a PI bull in which
BVDV was isolated from blood, semen and testis; the
semen was of acceptable quality, but some degenera-
tion of seminiferous tubules was reported.The present
report describes a PI bull with testicular hypoplasia
and the precise distribution of BVDV antigen within
the male genital tract as demonstrated by single and
double immunohistochemical labelling.
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Materials and Methods
Affected Animal and Samples
A16-month-old Brown Swiss bull in good body condi-
tionwas presented for examination at the Clinic of Re-
production, with a history of hypogonadism. Breeding
soundness evaluation revealed azoospermia in an eja-
culate collected by electroejaculation, bilateral testicu-
lar hypoplasia, and a persistent BVDV viraemia
detected by ELISA. The bull was slaughtered and
the entire genital tract submitted to the Institute of Ve-
terinary Pathology for further examination. After
macroscopical inspection, three tissue samples were
collected from the cranial, middle and caudal parts of
each testis. Other tissue samples were taken from the
epididymides (head, body and tail), ampulla, seminal
vesicles, bulbourethral glands, prostate gland, and ure-
thra (at the proximal and distal parts, sigmoid £exure,
and region of the glans penis). All samples were ¢xed in
4% formalin for 24 h, embedded in para⁄n wax and
further processed for sectioning (2 mm) and immuno-
histochemistry (IHC). For histopathology, adjacent
samples were ¢xed in Bouin’s solution for 18 h and
then transferred to 4% formalin for further routine
processing.
BVDV Antigen Detection in Formalin-fixed and Paraffin
Wax-embedded Tissue (EnVisionTM Method)
Samples of testes (left and right), epididymis (head and
tail), prostate gland, seminal vesicles (left and right),
bulbourethral glands (left and right) and urethrawere
examined by IHC. The slides were treated with xylol
before dehydration in graded alcohol concentrations,
and the counterstain used was haematoxylin (4min).
Antigen retrieval was carried out with Pronase
(S2013; Dako Cytomation, Zug, Switzerland) and the
slides were then incubated for10min at room tempera-
ture (RT) with an aqueous solution of H2O2 3% and
NaN3 0.2% to block endogenous peroxidase. Two dif-
ferent BVDV monoclonal antibodies, both speci¢c for
Erns/gp48, were used as primary antibodies, namely
C42 (kindly supplied by Prof.V. Moennig, Institute of
Virology, Hannover, Germany; diluted 1 in 400) and
15c5 (kindly supplied by Dr E. Dubovi, Cornell Uni-
versity, USA; diluted 1 in 10 000). After overnight incu-
bation at RTwith the primary antibodies, the EnVision
reagent (anti-mouse HRP; Dako) was applied, fol-
lowed by 3-amino-9-ethyl-carbazole (AEC; 00-2007
Substrate Kit; Zymed Laboratories, San Francisco,
CA, USA) as chromogen (Moennig et al.,1987; Haines
et al., 1992). Between each step, the slides were washed
with phosphate-bu¡ered saline (PBS; pH 8). Each
batch of slides included a positive control (hippocam-
pus of a BVDV-positive animal) and a negative control
(primary antibody replaced by PBS).
S-100 Immunohistochemistry (ChemMateTM Method)
S-100 was used as amarker for Sertoli cells. Antigen re-
trieval was carried out by boiling in citrate bu¡er
(S2031; Dako) in a microwave oven for 30min, before
the application of Peroxidase Blocking Agent (S2001;
Dako) for 5min at RT. The primary antibody, which
consisted of polyclonal rabbit anti-S-100 (H0066;
Dako), was then applied for 60min at RT. Slides were
subsequently treated with ChemMate Detection Kit
(K5003, rabbit/mouse, peroxidase; Dako), according
to the manufacturer’s instructions. AEC was used as
the chromogen. Nerve tissue was included as a positive
control.
Ferritin-Immunohistochemistry (EnVisionTM Method)
Ferritinwas used as amarker for Leydig cells. Blocking
of endogenous peroxidase with an aqueous solution of
H2O2 3% and NaN3 0.2% (10min, RT) was followed
by application (10min, RT) of a protein blocking agent
(X0909; Dako). Slides were treated overnight at RT
with rabbit anti-human ferritin (A0133; Dako).The sec-
ondary antibody (anti-rabbit EnVision; K4003; Dako)
was applied for 30min at RT, and AECwas used as the
indicator. Normal bovine testicular tissue was included
as a positive control.
Double Immunohistochemical Labelling
The Dako EnVision Doublestain System (K1395;
Dako) was used as described by the manufacturer. In
this system, a phosphatase-labelled polymer and subse-
quently an alkaline phosphatase-labelled polymer are
used as secondary antibodies. Double labelling experi-
ments were ¢rst carried out with 15c5 antibody and
anti-S-100 antibody, the chromogens being diamino-
benzidine (DAB) and fast red, respectively. Subse-
quently, double labelling experiments were performed
with 15c5 antibody and anti-ferritin antibody, again
with DAB and fast red, respectively.
Antigen ELISA
HerdChek*BVDVAg/Serum Plus (IDEXX Labora-
tories,Westbrook, ME, USA), performed according to
the manufacturer’s instructions, detects BVDV anti-
gens in serum, plasma, whole blood and‘‘ear notch’’ tis-
sue samples. In this method, the antigens are captured
on microtitre plates coated with speci¢c monoclonal
antibodies (Erns/gp44^48), positive samples being
identi¢ed by absorption values of40.03. In the present
study, serum and ejaculate from the positive animal
and from one control animal were tested.
ARTICLE IN PRESS
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Antibody ELISA
Serumwas tested for anti-BVDVantibodies with CHE-
KIT-BVD-Sero-II (Dr Bommeli AG, Bern-Liebefeld,
Switzerland). In this test microtitre plates are coated
with BVDVantigen (inactivated strain NADL).
Results
Macroscopical Findings
At necropsy, both testes were small (3�2 cm; circum-
ference 6 cm) but of normal shape, each weighing 27 g
(Fig. 1). The cut surface showed brown parenchyma of
normal consistency. The rete testis was of normal ap-
pearance. The epididymides and accessory glands ap-
peared small but of normal shape and consistency.The
urethrawas normal.
Histopathological Findings
Most of the seminiferous tubules of both testes were
small, with marked thickening of the basement mem-
branes.They were lined by a single layer of Sertoli cells
and the germinal epithelium was absent except for a
few remaining spermatogonia. The Leydig cells ap-
peared normal but prominent due to the small size of
the seminiferous tubules (Fig. 2).The epididymides, ac-
cessory glands, and urethra were normal. Spermato-
genesis was almost completely absent.
Immunohistochemical Findings
BVDV immunolabelling was seen in the media of the
vessel walls, particularly the arteries, in all organs ex-
amined. Cells in the seminiferous tubules were also po-
sitive for BVDV. Double labelling for BVDVand S-100
revealed that some Sertoli cells and the spermatogonia
that remained were BVDV-positive (Fig. 3). No Leydig
cells were BVDV-positive in either the single (BVDV)
or double (BVDV/ferritin) labelling assays. In the epi-
didymis, BVDV labelling was observed in the epithe-
lial cells of the ductus epididymidis, in some
spermatids in the ductuli e¡erentes, and in a few ¢bro-
cytes. In the prostate gland, BVDV immunolabelling
was seen in ¢brocytes, media cells of the vessels, the
glandular epithelial cells and sloughed cells in the lu-
minal secretion (Fig. 4). In the seminal vesicles, the
ARTICLE IN PRESS
Fig. 1. Bilateral testicular hypoplasia in a bull persistently infected
with BVDV. Scale in cm.
Fig.2. Testicular hypoplasia. Seminiferous tubules aremainly small,
with marked thickening of the basement membrane.Tubules
are lined by a single layer of Sertoli cells. Leydig cells appear
prominent due to the small size of seminiferous tubules.
HE. �20.
Fig. 3. Double immunolabelling of testicular tissue for BVDVanti-
gen (brown) and S-100 (red). Some Sertoli cells and still-ex-
isting spermatogonia are BVDV-positive. Arrows indicate
double-labelled Sertoli cells. IHC. �100.
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secretion,media cells of the vessels, and some ¢brocytes
and epithelial cells were strongly immunolabelled for
BVDV. In the bulbourethral gland, ¢brocytes, the
media cells of most vessels, and some epithelial cells of
the glands and around the lumenwere BVDV-positive.
In the urethra, vessel walls, ¢brocytes and the epithe-
lial cells lining the lumenwere also positive.
Antigen and Antibody ELISAs
Serum and ejaculate from the positive animal and one
control animalwere testedwith the HerdChek*BVDV
Ag/Serum Plus (IDEXX).The control animal was ne-
gative for BVDV antigen but the positive animal
showed high absorption values in both serum and eja-
culate (1.8). In the serum, no BVDVantibodies could be
detected.
Discussion
Persistent BVDV infection in a bull with testicular hy-
poplasia was shown immunohistochemically to be as-
sociated with BVDVantigen in various types of cell in
the genital tract. BVDV has a strong tropism for
epithelial cells and for media cells of blood vessels
(Haines et al., 1992; Thuº r et al., 1996; Brodersen, 2004).
In the present study, BVDVantigen was found in the
media of arterial walls in the testis, epididymis, ure-
thra, prostate, and vesicular and bulbourethral glands;
it was also identi¢ed in epithelial cells of the ductus epi-
didymidis, the accessory glands and the urethra. In ad-
dition, antigen was detected in the Sertoli cells of the
testis and to a lesser extent in the spermatogonia that
still remained, but not in Leydig cells. Givens et al.
(2003a) reported that BVDVantigenwas located with-
in the seminiferous tubules adjacent to the basement
membrane of two experimentally infected bulls. This
could not be con¢rmed in the present study because
the germinal epithelium of the seminiferous tubules
was almost completely absent in both testes. A propor-
tion of ¢brocytes throughout the genital tract were
BVDV-positive. By double IHC labelling, it proved
possible to identify precisely the cell types infectedwith
BVDVin the testis. Double immunolabelling of testicu-
lar sections demonstrated that BVDV-infected cells
consisted mainly of Sertoli cells, Leydig cells being ne-
gative. Antibodies to S-100 and ferritin were used to la-
bel Sertoli cells and Leydig cells, respectively. In the
bovine testis, S-100 is present in the cytoplasm and nu-
clei of Sertoli cells, in the epithelial cells of the straight
testicular tubules and rete testis, and in the endothe-
lium of capillaries, veins and lymphatic vessels (Amsel-
gruber et al., 1992,1994). A study in boars byWise et al.
(2003) showed that Leydig cells are the primary loca-
tion of ferritin and iron storage in the testes; such cells
can therefore be immunolabelled by ferritin antibo-
dies. As a result, it was possible to identify BVDV-posi-
tive cells by double labelling with BVDVantibody and
either S-100 or ferritin antibody. Barlow et al. (1986)
reported some positive labelling for BVDV in a few
small interstitial cells of a PI bull; however, in the pre-
sent study no Leydig cells were positive by single or
double labelling. Consistent with this ¢nding, the inter-
stitial cells were histologically normal.
The bull in the present study was infertile as a result
of azoospermia, causedby severe testicular hypoplasia.
Semen quality in PI bulls may vary. Revell et al. (1988)
described two cases of PI bulls with abnormalities of
the sperm head (collapsed head) but stated that this
was not necessarily linked to the virus. Barlow et al.
(1986) found the semen quality of a PI bull to be accep-
table, although there was some degeneration of the
seminiferous tubules; the bull, however, was shedding
virus in the semen, thereby presenting a risk of trans-
mission. Kirkland et al. (1991) reported that bulls with
an acute transient infection excreted the virus in se-
men; viral replication occurred mainly in the seminal
vesicles and prostate gland, and the virus was isolated
from the head and tail of the epididymis, and from
epithelial cells of the prostate gland and seminal vesi-
cles.
In PI cows, BVDVantigen has been detected by IHC
(Shin and Acland, 2001) in both epithelial and non-
epithelial cells in many organs, including the ovary and
uterus; as in the present study of the male genital tract,
BVDV-positive cellswere found inthe follicular, endome-
trial glandular and luminal epithelia, as well as in arter-
ialwalls of the ovaries anduterus.The ovaries represent a
possible site of BVDV replication, which may lead to
abnormal ovum development (Shin and Acland, 2001).
In PI cows the ovaries are often hypoplastic and the
ARTICLE IN PRESS
Fig. 4. Prostate. Glandular epithelial cells are BVD antigen-posi-
tive. IHC. �40.
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number of ovarian antral follicles signi¢cantly reduced
(Grooms, 2004).
BVDV causes many di¡erent congenital anomalies
and teratogenic e¡ects, but a direct association with
testicular hypoplasia has not been described. Previous
work in cows showed that BVDV infection may modu-
late the secretion of gonadotropins and sex steroids and
that non-cytopathogenic BVDV has the potential to
disrupt cell function of one or more components of the
hypothalamic-pituitary-ovarian axis (Fray et al., 2002).
If a similar disruption of the hypothalamic-pituitary-
testicular axis occurs in the bull, then it is conceivable
that testicular hypoplasia may be caused by BVDV.
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Abstract
To date, structures representing developmental stages of Chlamydia pneumoniae, especially persistent forms of this intracellular bacteria,
have not been described in human atherosclerotic tissues using specific antibody labeling and transmission electron microscopy.
Staining of atherosclerotic tissue from five patients seeking heart transplantation with gold-labeled antibodies specific for up-regulated
chlamydial heat shock proteins, GroEL and GroES, and visualisation via transmission electron microscopy revealed intracellular, atypical,
round to oval structures of variable diameter. These structures resembled reticulate bodies of Chlamydia, were surrounded by membranes and
were located within smooth muscle cells, macrophages or fibroblasts. By using double immunogold electron microscopy technique (GroEL
and GroES in combination with chlamydial LPS/MOMP antibodies), we demonstrated these structures were of chlamydial origin.
In the current study, we demonstrated the presence of aberrant bodies of C. pneumoniae in vivo in archival coronary atheromatous heart
tissues by the immunogold electron microscopy technique.
© 2007 Elsevier Ireland Ltd. All rights reserved.
Keywords: Atherosclerosis; Chlamydia pneumoniae; Immunogold electron microscopy; Persistent infection
1. Introduction
Over the last decade, a significant amount of data has
suggested a role of infection with Chlamydia (C.) pneumo-
niae in the pathogenesis of human atherosclerosis [1]. The
first isolation of C. pneumoniae in culture from coronary
atheroma was reported by our group in 1996 [2], and the
isolate was designated C. pneumoniae A03. In that study,
from 10 patients with coronary atherosclerosis who under-
went heart transplantation, C. pneumoniae was identified by
non-culture techniques in seven patients, but was isolated
∗ Corresponding author. Tel.: +41 44 635 8551; fax: +41 44 635 8934.
E-mail address: n.borel@access.unizh.ch (N. Borel).
1 Present address: Biological Defense Research Directorate, Naval Med-
ical Research Center, 12300 Washington Avenue, Rockville, MD 20852,
USA.
by culture in only one patient. To explain this poor isola-
tion rate, we speculated that the organism was not present
in the normal replicative form, but in a non-culturable,
aberrant form. Chlamydia species are able to persist at
the site of infection via an arrested state in the develop-
mental cycle known as aberrant body [3]. Several in vitro
models of persistent C. pneumoniae infections have been
described (e.g. interferon-�, iron-limitation, antibiotics), and
aberrant bodies were well characterised by transmission elec-
tron microscopy [3]. Indirect evidence of persistence in
vivo is described mainly in chronic C. trachomatis infec-
tions [3], but aberrant forms of C. pneumoniae have not
been described in humans thus far. Therefore, we devel-
oped a research plan to investigate the presence of these
in human coronary atheromas. First, we established a lab-
oratory model of arrested C. pneumoniae A03 infection
and created aberrant bodies by cytokine-induced amino acid
0021-9150/$ – see front matter © 2007 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.atherosclerosis.2007.09.026
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deprivation [4–6]. Second, using proteomic tools for analysis,
we characterised protein expression profiles of C. pneumo-
niae A03 aberrant bodies and identified two up-regulated
C. pneumoniae A03 proteins (GroEL and GroES) as tar-
gets [7,8]. GroEL (60 kDa chaperonin) and GroES (10 kDa
chaperonin) are both chaperons involved in protein fold-
ing, assembly and modification. Third, using the newly
identified protein targets, we developed specific antibod-
ies against five differentially expressed proteins (GroEL,
GroES, GspD, Ndk and Pyk) from C. pneumoniae aber-
rant bodies. General secretion protein D (GspD) is involved
in protein secretion, nucleoside-2-phosphate-kinase (Ndk)
is involved in base and nucleotide metabolism in amino
acid biosynthesis and pyruvate kinase (Pyk) is involved
in the energy metabolism (glycolysis and gluconeogene-
sis). GroEL and GroES were upregulated under persistence,
whereas GspD and Pyk remained unchanged and Ndk was
downregulated. We selected coronary atheromas from our
original heart transplant study [2] and identified granular
positive staining material in the cytoplasm of subintimal
macrophages and smooth muscle cells in the media of
the affected coronary arteries (atheromas) of heart trans-
plantation patients using tissue–microarray technology and
immunohistochemical labeling [9]. In the final step, with
the objective to determine whether C. pneumoniae aberrant
bodies are present in coronary atheromas, we designed a
study to demonstrate their ultrastructure by means of double
immunogold transmission electron microscopy and specific
antibodies to C. pneumoniae A03 proteins expressed during
persistent infection.
2. Methods
2.1. Patients
Archived coronary atheromatous tissue samples from our
original heart transplant study [2] were selected from the
patient (# 3) from whom C. pneumoniae A03 was isolated
and from two other patients where C. pneumoniae was
detected, but not cultured (patients # 1 and 12) (positive
patients). Coronary heart tissue from two patients (patients
# 7 and 11) who underwent heart transplantation because of
myocarditis, rather than atherosclerosis and were negative
for C. pneumoniae by culture, polymerase chain reaction
(PCR), immunohistochemistry (IHC), in situ hybridisation
(ISH) and transmission electron microscopy (TEM) served as
negative patients. All patients had convalescent C. pneumo-
niae titers as determined by an indirect immunofluorescent
antibody test [2].
2.2. Antibodies
Two proteins, GroEL and GroES, previously identified
as being up-regulated in the IFN-�-induced model of C.
pneumoniae A03 persistence [8] were plugged from a silver-
stained 2D gel and used for production of rabbit polyclonal
IgG-antibodies (Harlan Bioproducts for Science Inc., Indi-
anapolis, IN, USA). Sera were raised in pathogen-free,
barrier-raised New Zealand white rabbits immunised four
times with the antigens, and sera from the final bleed
were used in this study. The specificity of both antibodies
Fig. 1. Representative two-dimensional electrophoretic gels of C. pneumoniae A03 GroEL and GroES expressed at 48 hpi in interferon-�-treated HEp-2 cells.
(A) showing 35S-labeled GroEL and GroES, and (B) Western blot analysis of purified C. pneumoniae A03 elementary bodies against rabbit immune sera to
GroEL and GroES, respectively.
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was confirmed in our laboratory by Western Blot analy-
sis on 2D gel electrophoresis of purified C. pneumoniae
elementary body preparation, that demonstrated specific
reactivity on the blot corresponding to the molecular weight
and iso-electric point of each of the individual proteins
(Fig. 1).
GroEL and GroES antibodies have been described and
used previously for identifying C. pneumoniae-positive
atheromas by immunohistochemistry [9].
A Chlamydiaceae family-specific rabbit polyclonal anti-
body directed against both the chlamydial LPS and
the chlamydial major outer membrane protein (MOMP)
(pLPS/MOMP; Cygnus Technologies Inc., Southport, NC,
USA) was used as a control antibody for the single and double
immunogold labeling.
2.3. Transmission electron microscopy
Glutaraldehyde fixed osmium tetroxide fast fixed and
epon-embedded heart tissue specimens of the heart patients
# 1, 3, 7, 11 and 12 were examined. Uninfected and infected
(72 h) HEp-2 cell pellets were used as negative and positive
controls, respectively. Appropriate areas for ultrastructural
investigation were selected using semithin sections (1�m)
stained with toluidine blue (Fluka, Buchs SG, Switzerland).
Ultrathin sections (80 nm) were mounted on gold grids
(Merck Eurolab AG, Dietlikon, Switzerland), contrasted with
uranyl acetate dihydrate (Fluka) and lead citrate (lead nitrate
and tri-natrium dihydrate; Merck Eurolab AG) and investi-
gated for the presence of chlamydial developmental stages in
a Philips CM10 electron microscope.
2.4. Single immunogold labeling
The sections were labeled with the primary antibod-
ies pLPS/MOMP, GroEL, or GroES at room temperature.
After washing with PBS/TBS buffer for 30 min, the sam-
ples were incubated with 18-nm colloidal gold-conjugated
polyclonal IgG anti-rabbit secondary antibody (dilution
1:15) for 2 h. The sections were washed for another
20 min, rinsed with deionised water, and contrasted as
described.
2.5. Double immunogold labeling
This technique has been widely described in the liter-
ature (reviewed by Merighi 1992) [10] and was used in
this study to investigate whether the structures identified in
atherosclerotic myocardial tissue were indeed of chlamydial
origin. We used pLPS/MOMP and GroEL, GroES antibod-
ies. After washing the sections with PBS/TBS buffer for
30 min, they were incubated with 18-nm colloidal gold-
conjugated polyclonal anti-rabbit secondary antibody (1:15
dilution) for 2 h at room temperature. After a second washing
with PBS/TBS buffer for 30 min, the samples were incubated
with the pLPS/MOMP antibody at room temperature. After
Fig. 2. Transmission electron microscopy. (A) HEp-2 cell pellet infected
with C. pneumoniae for 72 h. Large intracytoplasmic chlamydial inclusion
containing various numbers of elementary bodies (EBs, arrow), reticulate
bodies (RBs, arrowhead), and intermediate bodies (IBs, circle). Nucleus (N)
of the infected cell and (B) Patient # 1, multiple intracellular round to oval
structures of variable diameter (0.6–1.5�m) resembling RBs of Chlamydia.
They are surrounded by membranes (arrows) and collagenous fibers (aster-
isks) and located within a fibroblast. These organisms contain multiple small
round moderately electron-dense particles probably representing condensed
chlamydial protein.
washing with PBS/TBS buffer for 30 min, the samples were
incubated with 6-nm colloidal gold-conjugated polyclonal
anti-rabbit secondary antibody (1:15 dilution) for 2 h. Finally,
the sections were washed for another 20 min and rinsed with
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Fig. 3. Single immunogold labeling. (A) HEp-2 cell-infected with C. pneumoniae for 72 h labeled with the GroES ab. Multiple, small, round moderately
electron-dense particles within EBs labeled with the GroES antibody and interpreted as condensed chlamydial protein (arrows). (B) Patient # 1 labeled with the
GroEL ab. Intracellular, atypical round to oval structures resembling RBs labeled with the GroEL ab. (C) Patient # 1 labeled with the GroES ab. Intracytoplasmic
structures containing multiple small, round particles labeled with the GroES ab. (D) Patient # 1 labeled with the GroES ab. Large, intracellular, membrane-bound
accumulation of multiple small (20 nm in diameter), electron-dense particles labeled with the GroES ab. (E) Patient # 11 labeled with the GroEL ab. Intracellular
round to oval structures resembling RBs labeled with the GroEL ab. (F) Patient # 11 labeled with the GroES ab. Intracellular accumulation of multiple, small
electron-dense particles labeled with the GroES ab.
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deionised water. HEp-2 cell monolayers inoculated with puri-
fied C. pneumoniae A03 elementary bodies were used as a
positive control. Negative controls consisted of uninfected
HEp-2 cell monolayers as well as coronary artery tissue
from two non-human primates (Macaca mulatta). All tissues
(HEp-2 cells infected and uninfected, patient specimens and
coronary tissue from non-human primates) were additionally
tested with the secondary gold-labeled anti-rabbit antibod-
ies omitting the primary antibodies to exclude non-specific
binding.
3. Results
The results of all five patients were comparable and
representative for multiple sections investigated. Selected
results, representative for all five patients, are shown in
Figs. 2B, 3B–D, 5C–D (patient # 1) and Fig. 3E and F (patient
# 11).
3.1. TEM
Large intracytoplasmic chlamydial inclusion bodies were
found in moderate numbers in the positive control HEp-2
cell pellet infected with C. pneumoniae at 72 hpi (Fig. 2A).
They contained various numbers of classical elementary
bodies (EBs), intact or dividing reticulate bodies (RBs),
and intermediate bodies (IBs). None of these structures
were detected in the uninfected HEp-2 cell pellet (data not
shown).
Transmission electron microscopy failed to demonstrate
any classical chlamydial inclusions containing any of the
classical developmental structures of C. pneumoniae, such
as EBs or dividing RBs in all the samples. On the other hand,
intracellular round to oval structures of variable diameter
(0.6–1.5�m), with features of aberrant bodies, were observed
in all five patients (Fig. 2B, patient # 1). These structures
resembled RBs of Chlamydia, were surrounded by mem-
branes and located within smooth muscle cells, macrophages
or fibroblasts (cell types were identified by morphology).
These organisms contained multiple small round moderately
electron-dense particles probably representing condensed
chlamydial protein. Similar particles were also free in host
cells (see immunogold-labeled images below).
3.2. Single immunogold labeling
EBs and RBs were labeled by all three of the
antibodies (pLPS/MOMP, GroEL and GroES) in the
infected HEp-2 cell pellet (positive control). Interest-
ingly, only the pLPS/MOMP antibody, but not the
GroEL and GroES antibodies labeled membrane struc-
tures. Multiple small, GroEL and GroES labeled round
moderately dense particles (20 nm diameter) within EBs
were interpreted as condensed chlamydial protein (Fig. 3A,
arrow).
Two types of structures were recognised in myocardial
tissue of both positive (# 1, 3, 12) and negative patients (# 7
and 11) using pLPS/MOMP ab, GroEL and GroES abs:
(i) spherical round to oval structures (size 0.6–1.5�m)
located predominantly within the cytoplasm of host cells
resembling aberrant chlamydial particles (Fig. 3B, C and
E);
(ii) multiple small (20 nm diameter) round to oval, moder-
ately electron-dense particles (Fig. 3D and F).
Single immunogold labeling with pLPS/MOMP ab in pos-
itive patients # 1, 3 and 12 was of moderate intensity with
minor differences between the three patients, whereas GroEL
Fig. 4. Single immunogold labeling. Electron microscopy of coronary tissue
from non-human primate labeled with the anti-LPS/MOMP ab (A) and the
anti-GroEL antibodies (B).
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Fig. 5. Double immunogold labeling. HEp-2 cell-infected with C. pneumoniae for 72 h labeled with the pLPS/MOMP ab (6-nm gold particles) and GroEL
ab (18-nm gold particles). Small gold particles (6-nm) indicate the reaction with LPS/MOMP, whereas large gold particles (18-nm) indicate the reaction with
GroEL. Electron microscopy of C. pneumoniae elementary bodies (A) and reticulate bodies (B) labeled with anti-LPS/MOMP and anti-GroEL antibodies in
HEp-2 cells. (C) Patient # 1 labeled with the pLPS/MOMP ab (6-nm gold particles) and GroEL ab (18-nm gold particles). Spherical round to oval structures
located within the cytoplasm of host cells are showing co-localisation of small (pLPS/MOMP ab) and large (GroEL ab) gold particles. (D) Patient # 1 labeled
with the pLPS/MOMP ab (6-nm gold particles) and GroEL ab (18-nm gold particles). Spherical round to oval structures located within the cytoplasm of host
cells are showing co-localisation of small (pLPS/MOMP ab) and large (GroEL ab) gold particles (left) as well as accumulation of small electron-dense particles
(right).
and GroES showed more marked reactions. The labeling in
the negative patients # 7 and 11 with all antibodies was weaker
than in the positive patients # 1, 3 and 12.
Uninfected HEp-2 cell monolayers (data not shown)
or non-human primate coronary tissues (Fig. 4A and B)
were negative with all primary antibodies. Similarly, all the
secondary gold-labeled anti-rabbit antibodies with omitted
primary antibodies were negative in all examined tissues
(HEp-2 cells infected and uninfected, patient specimens and
non-human primate coronary tissue).
3.3. Double immunogold labeling
Double immunogold labeling was confirmed in the pos-
itive control sections of infected HEp-2 cell monolayers
containing C. pneumoniae EBs (Fig. 5A) and C. pneu-
moniae RBs (Fig. 5B). RBs were mainly labeled by the
pLPS/MOMP ab in the infected HEp-2 cell pellet, whereas
there was an obvious co-localisation of pLPS/MOMP and
GroEL and GroES, respectively in EBs. Membrane struc-
tures were mainly labeled by the pLPS/MOMP ab. Multiple,
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small, round moderately dense particles (20 nm diameter)
within EBs, which were interpreted as condensed chlamy-
dial protein were labeled by the GroEL and GroES ab,
but also with the pLPS/MOMP ab to a lesser extent
(Fig. 5A).
Double immunogold labeling in the heart patients demon-
strated co-localisation of pLPS/MOMP and GroEL and
GroES labeling in the two types of structures positive in the
single immunogold technique (Fig. 5C and D). Thus, it could
be confirmed that the structures identified in atherosclerotic
tissues were indeed of chlamydial origin.
4. Discussion
In this study, we demonstrated the presence of aberrant
or persistent bodies of C. pneumoniae in human coronary
atheromas. We observed intracellular atypical structures in
atherosclerotic tissue of five heart patients by using GroEL
and GroES antibodies against up-regulated chlamydial heat
shock proteins in combination with chlamydial LPS/MOMP
antibodies in double immunogold electron microscopy. We
demonstrated that these bodies were indeed of chlamydial
origin. Such structures are not consistently detectable by cur-
rently used methods and antibodies. Although we could not
demonstrate typical C. pneumoniae RBs or EBs in atheroma-
tous tissue, we were able to show that chlamydial heat shock
proteins are expressed on the surface of persistent bodies,
apparently free in the cytoplasm of infected cells. Potentially,
they provide a source of chronic inflammatory stimulation in
the absence of replicating chlamydial forms (RBs).
We detected a higher proportion of positive patients
with experimentally produced GroEL and GroES antibodies
than in the previous study [2]. We showed that these up-
regulated proteins from proteomic analysis were expressed
in C. pneumoniae-infected human atheromatous myocardial
tissues and were detectable morphologically within lesions
via immunogold labeling. Also labeled chlamydial struc-
tures were detected in patients # 7 and 11 undergoing heart
transplantation as a sequel to myocarditis, rather than severe
atherosclerosis (unpublished data). The finding of C. pneu-
moniae within coronary arteries in patients # 7 and 11 is not
surprising, since they were already over 50 years old. Since
it is highly likely that atherosclerosis begins in childhood it
is likely that they were correspondingly affected. This likeli-
hood is partially supported by the detection of convalescent
antibody titers in these two patients [2].
Our findings have several implications in the proposed
association of infection with C. pneumoniae with the athero-
genic process in humans. Atherosclerosis is a chronic
inflammatory disease [11]. Thus, in order for C. pneumoniae
to play a causative role, the organism must persist within
atheromatous tissue for extended periods of time. Our study
indicates that C. pneumoniae is present at the site of infection
in the form of aberrant bodies, an alternative replicative form
of C. pneumoniae. A persistent C. pneumoniae infection of
human atheromas with associated chronic inflammation may
be linked to atherosclerosis. The presence of a chronic C.
pneumoniae infection in the form of aberrant bodies explains
the large number of studies where C. pneumoniae cultures
were unsuccessful although DNA was detected in atheromas
[1]. Since these aberrant bodies are in a non-replicative state,
they are less susceptible to antibiotic activity [12]. Therefore,
a chronic infection characterised by the prevalence of these
aberrant bodies may explain the failure of anti-C. pneumo-
niae antibiotics to prevent coronary events in patients with
atherosclerosis [13].
An important limitation of this study is the small spec-
trum of examined material. A prospective study of coronary
arteries of patients requiring heart transplantation is neces-
sary to corroborate our findings. Antimicrobial therapy will
not prevent disease if a chronic C. pneumoniae infection with
aberrant bodies turns out to be a cause for atherosclerosis. It
is important to continue to investigation of the role of C.
pneumoniae in atherosclerosis since vaccination may prove
to be the solution in the prevention of chronic C. pneumoniae
infections.
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Abstract
Background: Enteropathogenic Escherichia coli (EPEC), mainly causing infantile diarrhoea,
represents one of at least six different categories of diarrheagenic E. coli with corresponding distinct
pathogenic schemes. The mechanism of EPEC pathogenesis is based on the ability to introduce the
attaching-and-effacing (A/E) lesions and intimate adherence of bacteria to the intestinal epithelium.
The role and the epidemiology of non-traditional enteropathogenic E. coli serogroup strains are not
well established. E. coli O157:H45 EPEC strains, however, are described in association with
enterocolitis and sporadic diarrhea in human. Moreover, a large outbreak associated with E. coli
O157:H45 EPEC was reported in Japan in 1998. During a previous study on the prevalence of E.
coli O157 in healthy cattle in Switzerland, E. coli O157:H45 strains originating from 6 fattening cattle
and 5 cows were isolated. In this study, phenotypic and genotypic characteristics of these strains
are described. Various virulence factors (stx, eae, ehxA, astA, EAF plasmid, bfp) of different
categories of pathogenic E. coli were screened by different PCR systems. Moreover, the capability
of the strains to adhere to cells was tested on tissue culture cells.
Results: All 11 sorbitol-positive E. coli O157:H45 strains tested negative for the Shiga toxin genes
(stx), but were positive for eae and were therefore considered as EPEC. All strains harbored eae
subtype D1. The gene encoding the heat-stable enterotoxin 1 (EAST1) was found in 10 of the 11
strains. None of the strains, however, carried ehx A genes. The capability of the strains to adhere
to cells was shown by 10 strains harbouring bfp gene by localized adherence pattern on HEp-2 and
Caco-2 cells.
Conclusion: This study reports the first isolation of typical O157:H45 EPEC strains from cattle.
Furthermore, our findings emphasize the fact that E. coli with the O157 antigen are not always STEC
but may belong to other pathotypes. Cattle seem also to be a reservoir of O157:H45 EPEC strains,
which are described in association with human diseases. Therefore, these strains appear to play a
role as food borne pathogens and have to be considered and evaluated in view of food safety
aspects.
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Background
Enteropathogenic Escherichia coli (EPEC), mainly causing
infantile diarrhoea, represents one of the at least six differ-
ent categories of diarrheagenic E. coli with corresponding
distinct pathogenic schemes [1]. Most of the EPEC strains
belong to a series of O antigenic groups known as EPEC O
serogroups: O26, O55, O86, O111, O114, O119, O125,
O126, O127, O128, O142 and O158.
The main mechanism of EPEC pathogenesis is the ability
to introduce attaching-and-effacing (A/E) lesions on
intestinal cells characterized by microvillus destruction,
intimate adherence of strains to the intestinal epithelium,
pedestal formation and aggregation of polarized actin at
sites of bacterial attachment [2].
The genetic determinants for the production of A/E
lesions are located on the locus of enterocyte effacement
(LEE), a pathogenicity island that contains the genes
encoding intimin (eae), a type III secretion system, a
number of secreted proteins (ESP) and the translocated
intimin receptor (Tir) [2]. Characterization of eae genes
revealed the existence of different eae variants. At present,
15 (D1, D2, E1, E2, J1, J2/T, G/N, H, ], K, L, O, P, Q, [) genetic
variants of the eae gene have been identified [3-7]. It is dis-
cussed that different intimins may be responsible for dif-
ferent host- and tissue cell tropism [8,9]. In epithelial
culture cells EPEC strains produce characteristic adher-
ence patterns: (i) localized adherence (LA), where micro-
colonies attach after 3 hours incubation to one or two
small areas on the cells [10,11]; (ii) diffuse adherence
(DA), where bacteria cover the cells uniformly [10]; (iii)
enteroadherent-aggregative adherence (AA), where the
bacteria have a characteristic stacked-brick-like arrange-
ment [12] and (iiii) localized adherence-like adherence
(LAL), characterized by formation of less-compact micro-
colonies or clusters of bacteria than those by LA [13].
Localized adherence is associated with the presence of the
large EPEC adherence factor (EAF) plasmid, on which also
the cluster of genes encoding bundle-forming pili (BFP) is
present [1]. EPEC are classified as typical, when possessing
the EAF plasmid; whereas atypical EPEC strains do not
possess the EAF plasmid [14,15].
Typical and atypical EPEC strains usually belong to certain
serotype clusters, differ in their adherence patterns on cul-
tured epithelial cells (typical: LA; atypical: DA; AA; LAL),
are typically found in different hosts (typical EPEC strains
have only been recovered from humans), and display dif-
ference in their intimin types [15].
The role and the epidemiology of non-traditional enter-
opathogenic E. coli serogroup strains in human diarrhea
are not well established. E. coli O157:H8 and E. coli
O157:H45 EPEC strains have been described to be associ-
ated with diarrhea in human [4,16]. Makino et al. [17]
reported the first large outbreak with E. coli O157:H45
EPEC in Japan in 1998. Nevertheless, these O157 EPEC
strains are not well characterized.
This study reports the first isolation of O157:H45 EPEC
strains from cattle and phenotypic and genotypic charac-
teristics of the isolated strains are described.
Results and discussion
All 11 sorbitol-positive E. coli O157:H45 strains, six
strains isolated from fattening cattle and five strains iso-
lated from cows tested negative for Shiga toxin genes (stx).
The eae gene, which is strongly correlated to the attaching-
and-effacing lesions, was present in all strains. Therefore,
these strains are considered to be EPEC. Our findings
emphasize the fact that E. coli with the O157 O antigen are
not always STEC but may belong to other pathotypes. Fur-
ther results of strain characterization are shown in Tab. 2.
In all tested strains, LEE was inserted in selC and thus these
strains could be evolutionarily more akin to the EPEC 1
and EHEC 1 clones than to other clones [18]. Further
characterization of the eae variants showed in all strains
eae subtype D1. Oswald et al. [4] testing in their study the
distribution of intimin types among different EPEC
strains, found the same eae subtype in O157:H45 strains
isolated from human with diarrhea.
The gene encoding the heat-stable enterotoxin (EAST1),
representing an additional determinant in the pathogene-
sis of E. coli diarrhea, was found in ten of the 11 strains.
None of the strains, however, carried ehxA genes.
Nine strains were positive for the EAF plasmid and 10
strains harbored the bfpA gene encoding bundlin, the
structural subunit of the bundle-forming pilus expressed
by typical EPEC strains. The EAF plasmid negative but
bfpA positive strain may have a defect in the EAF region
that does not interfere with the plasmid's function. All
bfpA gene positive strains showed a localized adherence
(LA) pattern, the penotpyical characteristic associated
with the expression of bundle-forming pili and therefore
seem to be a typical EPEC. For HEp-2 and Caco-2 cells
similar results were obtained (Figure 1, 2). Caco-2 cells
instead of Hela cells were used for adhesion assay and FAS
test, because they represent a system close to the human
intestinal cells. Furthermore, Vieira et al. [19] have shown
that results obtained by Caco-2 cells are comparable to
Hela cells.
10 of the 11 strains showed an A/E property with the flu-
orescent actin staining (FAS) test (Figure 3).
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According to Kaper [14] most of our O157:H45 strains
have to be classified as typical EPEC strains, because they
are possessing the EAF plasmid and are showing the local-
ized adherence (LA) pattern. However, they are harboring
astA genes, which is more common for atypical EPEC
strains [15].
Further studies are needed to evaluate the role of such
EPEC strains isolated from asymptomatic animals.
Conclusions
Cattle have not only to be considered as important
asymptomatic carriers of O157 STEC but can also be a res-
ervoir of O157 EPEC strains, which are described in asso-
ciation with human diseases. These strains appear to play
a role as food borne pathogens and have to be considered
in view of food safety aspects.
Table 1: Sequences and predicted lengths of PCR amplification products of oligonucleotide primers used
Target Primer Oligonucleotide sequence (5'-3')Sequence Product size Reference
stx VT1 ATTGAGCAAAATAATTTATAT GTG 523 bp 21
VT2 TGATGATGGCAATTCAGTAT 520 bp
eae SK1 CCCGAATTCCGCACAAGCATAAGC 863 bp 22
SK2 CCCGGATCCGTCTCGCCAGTATTCG
eae-D1 EAE-FB AAAACCGCGGAGATGACTTC 820 bp 7
EAE-A CACTCTTCGCATCTTGAGCT
eae-D2 IH2498aF AGACCTTAGGTACATTAAGTAAGC 517 bp 7
IH2498aR TCCTGAGAAGAGGGTAATC
eae-E1 EA-B1-F CGCCACTTAATGCCAGCG 811 bp 7
EAE-B CTTGATACACCTGATGACTGT
eae-E2 EA-B2-F CCCGCCACTTAATCGCACGT 807 bp 7
EAE-B CTTGATACACCTGATGACTGT
eae-J1 EAE-FB AAAACCGCGGAGATGACTTC 804 bp 7
EAE-C1 AGAACGCTGCTCACTAGATGTC
eae-J2/T EAE-FB AAAACCGCGGAGATGACTTC 808 bp 7
EAE-C2 CTGATATTTTATCAGCTTCA
eae-G/N EAE-FB AAAACCGCGGAGATGACTTC 833 bp 7
EAE-D CTTGATACACCCGATGGTAAC
eae-H EAE-FB AAAACCGCGGAGATGACTTC 722 bp 7
LP5 AGCTCACTCGTAGATGACGGCAAGCG
eae-] Z1 GGTAAGCCGTTATCTGCC 206 bp 7
Z2 ATAGCAAGTGGGGTGAAG
eae-K EAE-FB AAAACCGCGGAGATGACTTC 712 bp 7
LP8 TAGATGACGGTAAGCGAC
eae-L EAE-FB AAAACCGCGGAGATGACTTC 807 bp 7
LP7 TTTATCCTGCTCCGTTTGCT
eae-O 68.4F CGGTCAGCCTGTGAAGGGC 466 bp 7
68.4R ATAGATGCCTCTTCCGGTATT
eae-P FV373F CAACGGTAAGTCTCAGACAC 443 bp 7
FV373R CATAATAAGCTTTTTGGCCTACC
eae-Q IH1229aF CACAGCTTACAATTGATAACA 311 bp 7
IH1229aR CTCACTATAAGTCATACGACT
eae-[ EAE-FB AAAACCGCGGAGATGACTTC 468 bp 7
B49R ACCACCTTTAGCAGTCAATTTG
ehxA HlyA1 GGTGCAGCAGAAAAAGTTGTAG 1551 bp 23
HlyA2 TCTCGCCTGATAGTGTTTGGTA
astA EAST1 CCA TCA ACA CAG TAT ATC CGA 111 bp 24
EAST2 GGT CGC GAG TGA CGG CTT TGT
EAF EAF1 CAG GGT AAA AGA AAG ATG ATA A 397 bp 25
EAF25 TAT GGG GAC CAT GTA TTA TCA
bfpA EP1 AAT GGT GCT TGC GCT TGC TGC 326 bp 26
EP2 GCC GCT TTA TCC AAC CTG GTA
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Methods
Origin of the E. coli strains
The strains characterized in this work were isolated during
a recent study on prevalence of E. coli O157 in healthy cat-
tle in Switzerland [20]. The study was based on investiga-
tions that were carried out within the last one and a half
years (January 2002 – June 2003) in two EU-approved
slaughterhouses. From 2,930 bovine fecal samples (1,183
Localized adherence (LA) pattern of the E. coli O157:H45 strain 1070/03 on HEp-2 cellsFigure 1
Localized adherence (LA) pattern of the E. coli O157:H45 strain 1070/03 on HEp-2 cells. (a) 3 h assay, (b) 6 h assay
Localized adherence (LA) pattern of the E. coli O157:H45 strain 1070/03 on Caco-2 cellsFigure 2
Localized adherence (LA) pattern of the E. coli O157:H45 strain 1070/03 on Caco-2 cells. (a) 3 h assay, (b) 6 h assay
a       b
a      b
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calves, 1,201 fattening cattle and 546 cows), 11 sorbitol-
fermenting E. coli O157:H45 strains (from 6 fattening cat-
tle and 5 cows) were isolated. The determination of the O
and H antigens was performed as previously described
using all available O (O1 to O181) and H (H1 to H56)
antisera [6].
Genotypic characterization of the O157:H45 strains
PCR for the detection of putative virulence genes were per-
formed in a T3 thermocycler (Biometra, Germany). PCR
reagents were purchased from PROMEGA (Madison,
Wis.) and primers were synthesized by MICROSYNTH
(Balgach, Switzerland). The 50-Pl PCR mixtures normally
consisted of 2 Pl of bacterial suspension in 42 Pl of dou-
ble-distilled water, 5 Pl of 10-fold-concentrated
polymerase synthesis buffer containing 2.0 mM MgCl2,
200 PM (each) desoxynucleosid triphosphate (dNTP), 30
pmol of each primer and 2.5 U of Taq DNA polymerase.
The PCR primers, target sequences and product sizes are
listed in Table 1. Differences in the normal PCR mixture
and cycling conditions for each PCR were previously
described in the cited literature.
To verify whether LEE was inserted downstream of the
selC locus, PCR reactions that amplify the junctions of this
locus with the E. coli chromosome were performed
according to Sperandio et al. [27]. Primers K255 (5'-
GGTTGAGTCGATTGATCTCTGG-3') and K260 (5'-
GAGCGAATATTCCGATATCTGGTT-3') were used for the
right junction; K296 (5'-CATTCTGAAACAAACTGCTC-3')
and K295 (5'-CGCCGATTTTTCTTAGCCCA-3') for the left
junction, and K261 (5'-CCTGCAAATAAACACGGCGCAT-
3') and K260 for the intact selC gene.
Adhesion assay and FAS test
E. coli colonies were characterized by the pattern of adher-
ence to HEp-2 and Caco-2 cells as described by Karch et al.
[28] with minor modifications. Briefly, HEp-2 and Caco-
2 cells were grown for 48 h with 5% CO2 on sterilized
coverslips (13 mm diameter; Bibby Sterilin™ Ltd., Stone,
England) in 24-well flat-bottom tissue culture plates with
low evaporation lid (16 mm diameter; BD Falcon™, Bed-
ford, USA) containing Minimum essential medium (MEM
with Earle's salts, 25 mM HEPES, without L-
Glutamine;GIBCO™ Invitrogen AG, Basel, Switzerland)
supplemented with fetal calf serum (FCS, 10%, Bio Con-
cept™, Allschwil, Switzerland), MEM Non Essential
Amino Acids (MEM NEAA (100x) without L-Glutamine,
GIBCO™ Invitrogen AG, Basel, Switzerland) and
GlutaMAX™I Supplement 200 mM (100x), (GIBCO™ Inv-
itrogen AG, Basel, Switzerland). Bacteria used for the
adhesion assay were grown over night in LB-broth Miller
(Becton Dickinson, Maryland, USA). Prior to incubation,
the confluent cells were washed two times with Dul-
becco's phospate buffered saline (D-PBS (1x) without Cal-
cium and Magnesium, GIBCO™ Invitrogen AG, Basel,
Switzerland). E. coli diluted 1:100 in 1 ml fresh media
(MEM with supplements) was added to the cells and was
incubated for 3 h at 37°C and 5% CO2. After this incuba-
tion period, monolayers were washed five times with D-
PBS (3 h assay) or monolayers were washed ten times with
D-PBS, fresh media (MEM with supplements) was added
and an additional incubation period of 3 h proceeded (6h
assay). Subsequently, the monolayers were washed five
times with D-PBS and the cells were fixed for 10 min with
4 Methanol. After the staining with May-Grünwald-
Giemsa (Fluka™, Buchs SG, Switzerland), the coverslips
were examined by light microscopy to determine the
adherence patterns of the strains.
The following fluorescent actin-staining (FAS) test was
performed on Caco-2 cells according to Karch et al. [28]
with minor modifications. The cells were fixed with 4%
formaldehyde in D-PBS, then washed three times with D-
Actin fluorescence micrograph showing E. coli O157:H45 strai  1070/03-inf cted Caco-2 cellsFigure 3
Actin fluorescence micrograph showing E. coli O157:H45 
strain 1070/03-infected Caco-2 cells
Table 2: Characterization results of 11 sorbitol-fermenting 
O157:H45 EPEC strains isolated from cattle in Switzerland
No. of 
strains
LEE in 
selC
Intimin 
type
EAF 
Plasmid
bfp Adherence 
pattern
astA ehx
9 yes D1 + + LA + -
1 yes D1 - + LA + -
1 yes D1 - - NA - -
LA: localized adherence; NA: no adherence
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PBS and incubated for 5 min with 0.1% Triton X-100
(Fluka™, Buchs SG, Switzerland) in D-PBS. After another
three washes with D-PBS, the monolayers were incubated
with 5 Pg/ml of fluorescein isothiocyanate labelled pha-
loidin (Sigma, Steinheim, Germany) for 30 min. After
another three washes with D-PBS, the coverslips were
examined by fluorescence microscopy (Leica ™).
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Abstract
Chlamydiae cause abortion and reproductive disorders in sows. Although organisms can infect the male genital tract, little is
known about the disease situation in boars. Hence, we examined the prevalence of chlamydial infection in semen and genital
tracts of boars. Samples collected from Swiss boars (group A: n = 42), and boars from Germany (group B: n = 39) were
examined by bacteriology, LPS-ELISA, immunohistochemistry (IHC) and polymerase chain reaction (PCR). The latter
methodology involved use of three PCR assays including 16Sig rDNA, IGS-S (intergenic spacer 16S/23S-Short) and IGS-
L (intergenic spacer 16S/23S-Long) PCR for comparison methods. PCR sensitivity and the presence of potential PCR inhibitors
were determined by spiking semen with Chlamydophila (Cp.) abortusDNA. Detection limits of the 16Sig and IGS-S PCR were
10 templates, while the IGS-L PCR was less sensitive (100 templates). Of 25 semen samples that were collected from group A,
one semen sample was positive for Cp. psittaci and twowere positive for Chlamydia-like organisms by 16Sig PCR. Screening of
sera from Swiss boars revealed three animals with positive reactions in the LPS-ELISA, although we failed to detect chlamydiae
within organs of these or sera-negative animals by IHC or IGS-S PCR. In group B, 10 ejaculates were positive for Chlamydia
(C.) suis and two were positive for Chlamydia-like organisms by 16S PCR. The identification of DNA from Chlamydia-like
organisms in semen from both groups of boars was surprising and a role for these bacteria in reproductive diseases requires
further assessment. In conclusion, the prevalence of chlamydial infection was low in group A animals indicating that venereal
transmission may not be significant for Chlamydia-associated reproductive diseases in pigs, although rare cases may occur.
# 2006 Elsevier B.V. All rights reserved.
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1. Introduction
Chlamydial infections in pigs are associated with a
variety of clinical disorders including respiratory
www.elsevier.com/locate/vetmic
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disease, conjunctivitis, enteritis and reproductive
disorders (Wittenbrink et al., 1991; Rogers et al.,
1996; Rogers and Andersen, 1996, 1999). Several
chlamydial species have been reported in pigs
including Chlamydia (C.) suis, Chlamydophila (Cp.)
psittaci, Cp. abortus, and Cp. pecorum. Many studies
have focused on the involvement of Chlamydia with
problems of reproductive failure and abortion (Wool-
len et al., 1990; Thoma et al., 1997). Serological
studies in European countries revealed high preva-
lence of chlamydial infection on pig breeding farms
(Vanrompay et al., 2004) and in sows with reproduc-
tive problems (Eggemann et al., 2000). Moreover,
several reports demonstrated the presence of chlamy-
dial DNA in genital tracts of sows with reproductive
failures (Hoelzle et al., 2000; Camenisch et al., 2004).
A Swiss study indicated that 3.6% of abortions in pigs
were Chlamydia associated (Thoma et al., 1997).
The presence of Chlamydia in the genital organs of
male animals (bulls) displaying epididymitis, orchitis
and seminal vesiculitis was first described in the 1960s
(Ball et al., 1964; Storz et al., 1968). Chlamydia was
also later isolated from lesions in the genital tract of a
boar (Sarma et al., 1983) and more recently, the
presence of Chlamydia in semen of boars, bulls and
men was confirmed by immunofluorescence (Veznik
et al., 1996). Moreover, several studies have revealed
that chlamydiae could survive in cryopreserved semen
of bulls (Storz et al., 1968) and men (Sherman and
Jordan, 1985). This finding may have significant
repercussions to the common practice of artificial
insemination (AI) worldwide.
Little is known about the prevalence of Chlamydia
in boars, and consequently about the venereal
transmission of Chlamydia in pigs. Therefore, we
evaluated suitable PCR assays for detection of
Chlamydia in boars, and subsequently used different
techniques including PCR for investigating the
prevalence of Chlamydia in boars.
2. Materials and methods
2.1. Animals: semen samples and male genital
organs
A total of 81 animals were divided into two groups.
Group A consisted of 42 boars (Nos. 1–42), aged
between 6 months and 5-year-old, from different
sources in Switzerland including an artificial insemina-
tion (AI) centre (n = 15), natural breeding (n = 14), and
slaughter house (n = 13). GroupB consisted of 39 boars
(Nos. 43–81) derived from four different AI centres
(AI1–4) in Germany. Specimens collected from group
A included genital tract organs (n = 41), semen samples
(n = 25) and sera (n = 23). Specimens from group B
were limited to semen samples only (n = 39). Details of
the two groups are summarised in Table 1.
Semen samples (groups A and B: n = 64), collected
during breeding soundness examination, were ali-
quotted and stored at �80 8C prior to testing.
Male genital organs (n = 41) were collected from
boars in group A after slaughtering. Three sections
from both testes (middle part, head and caudal
extremity) were collected for testing. Other genital
organs including three parts of the epididymides
(head, body and tail), prostate glands, seminal
vesicles, bulbourethral glands, the prepuce and four
parts of urethra (proximal, sigmoid flexure, distal and
glans penis) were also sampled. All organ samples
K. Teankum et al. / Veterinary Microbiology 116 (2006) 149–157150
Table 1
Groups of boars from Switzerland (A) and from Germany (B)
Samples Group A (Switzerland) Group B (Germany), AI centres
AI centre Natural breeding Slaughter housea
Ejaculates
(total n = 64)
(n = 15) No. 1–15 (n = 10) No. 16–25 na (n = 39) AI-1: No. 43–63, AI-2:
No. 64–70, AI-3: No. 71–79,
AI-4: No. 80–81
Genital organs
(total n = 41)
(n = 15) No. 1–15 (n = 13) No.
16–24, 26–29
(n = 13)
No. 30–42
na
Sera (total n = 23) (n = 13) (n = 10) na na
AI: artificial insemination; na: not available.
a 6-month-old boars, not exposed to sows.
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were fixed in 4% formalin, embedded in paraffin and
further processed for immunohistochemistry (IHC).
2.2. DNA extraction
The extraction of DNA from semen samples was
performed using the QIAamp DNA kit (Qiagen,
Hilden, Germany) using the body fluid protocol
described in the manufacturer’s instructions. Two
hundred microlitres of each semen sample were used
as the starting material.
For genital organ samples, 10 mm sections were cut
from each paraffin block with three sections from the
same case pooled together and placed in a sterile
microcentrifuge tube. DNAwas extracted using 200 ml
of extraction buffer (0.5% Tween-20, 1 mM EDTA,
50 mMTris–HCl, pH8.5).After incubation at 95 8C for
10 min, the samples were centrifuged (13,200 rpm,
4 8C, 30 min), and paraffinwas carefully removed. Two
microlitres of proteinase K (20 mg/ml) were added and
incubated at 55 8C overnight, followed by incubation
for 10 min at 95 8C. Extracted DNA was stored at
�20 8C. One microlitre was used as DNA template for
PCR reaction (IGS-S PCR assay).
2.3. Polymerase chain reaction (PCR)
Three PCR assays were used to detect chlamydial
DNA in semen samples.
2.3.1. 16S rDNA PCR signature sequence assay
(16Sig)
The primer pair 16S-IGF (50-GATGAGGCATG-
CAAGTCGAACG-30) and 16S-IGR (50-CCAGTGT-
TGGCGGTCAATCTCTC-30), slightly modified from
that described by Everett et al. (1999), was used to
amplify a 278 bp product of the 16S rRNA gene
specific for members of the order Chlamydiales. One
microlitre of extracted DNA was added into a PCR
mixture with final concentration of 3.5 mM MgCl2,
0.2 mM dNTPs, 1 mM of each primer (Microsynth,
Balgach, Switzerland), 5 ml of 10� buffer, 2 U of Taq
polymerase (AmpliTaq Gold, Applied Biosystems,
Rotkreuz, Switzerland) and dH2O to yield a final
volume of 50 ml. The amplification was performed in
45 cycles with initial denaturation (95 8C, 15 min),
followed by 45 cycles of denaturation at 94 8C for
30 s, annealing at 70 8C for 30 s, and extension at
72 8C for 45 s, with a final extension at 72 8C for
10 min.
2.3.2. IGS-short (IGS-S) PCR assay
The primer pair cIGS-1f (50-CAAGGTGAGGCT-
GATGAC-30) and cIGS-2r (50-TCGCCTKTCAATGC-
CAAG-30) was designed to target a variable region of
chlamydial DNA approximately 370 bp in length
including 80 bp of the 16S rRNA gene, 240 bp of the
rRNA intergenic spacer (IGS) region (depending on
chlamydial strain), and 50 bp of the 23S rRNA gene.
PCR was performed in 50 ml reaction volume contain-
ing 1 ml of DNA template, 0.25 mM of forward primer
(cIGS-1f), 0.5 mM reverse primer (cIGS-2r), 0.4 mM
dNTPs, 3.5 mM MgCl2, 5 ml of 10� buffer, 2.5 U of
Taq polymerase (AmpliTaq Gold, Applied Biosystems,
Rotkreuz, Switzerland) and dH2O to yield a final
volume of 50 ml. Amplification conditions were 40
cycles with initial denaturation (94 8C, 10 min),
followed by 45 cycles of denaturation at 94 8C for
30 s, annealing at 48 8C for 30 s, and extension at 72 8C
for 45 s, with a final extension at 72 8C for 10 min.
2.3.3. IGS-long (IGS-L) PCR assay
Primer pair cIGS-1f (50-CAAGGTGAGGCTGAT-
GAC-30) and IGS-1r (50-AGTGGTCTCCCCAGATT-
C-30) as recently described by Lutz-Wohlgroth et al.
(2006) was used to amplify an approximately 750 bp
PCR product containing 80 bp of the 16S rRNA gene,
240 bp of the IGS region (of variable length between
chlamydial species), and 440 bp of the 23S rRNA
gene. The PCR mixture contained 1.5 mM MgCl2,
1 mM of dNTP, 0.25 mM of each primer, 5 ml of
10� buffer, 2.5 U of Taq DNA polymerase (AmpliTaq
Gold, Applied Biosystems, Rotkreuz, Switzerland)
and dH2O to yield a final volume of 50 ml.
Amplification was performed in 40 cycles with initial
denaturation (94 8C, 10 min), followed by denatura-
tion at 94 8C for 30 s, annealing at 54.4 8C for 30 s and
extension at 72 8C for 45 s with a final extension at
72 8C for 10 min.
Negative controls were performed using a reaction
mixture with dH2O substituted for template DNA.
Template DNA for positive controls was obtained
from genomic DNA of Cp. abortus S26/3 (kindly
provided by GE Jones, Moredun Research Institute,
Edinburgh, Scotland). All PCR reactions were carried
out in a TGRADIENT thermal cycler (Biometra,
K. Teankum et al. / Veterinary Microbiology 116 (2006) 149–157 151
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Go¨ttingen, Germany). PCR products (5 ml) from all
PCR assays were separated by electrophoresis in 1.5%
agarose gels and visualized under UV transilluminator
for bands of the expected size.
2.4. Sensitivity of Chlamydia-specific PCRs
2.4.1. Preparation of genomic Cp. abortus DNA
for spiking experiment (PCR)
Confluent HEp-2 cell layers were infected with
Cp. abortus S26/3 (multiplicity of infection
(MOI) = 0.5) for three consecutive days and grown
for 216 h. Supernatant was removed and replaced by
growth medium every 72 h. Supernatant was subse-
quently collected and centrifuged at 250 g to remove
the remaining cell debris. Ten percent DMSO was
added to the supernatant, and 1 ml aliquots were
stored at �80 8C. Two milliliter of frozen aliquots
was used to prepare genomic chlamydial DNA.
Protein was digested by incubation of supernatant
with 50 mg/ml proteinase K in a 200 mM Tris–HCl
(pH 8.0), 25 mM EDTA (pH 8.0), 300 mM NaCl, 2%
SDS solution overnight at 55 8C. Remaining protein
was removed by three phenol/chloroform extractions
followed by ethanol precipitation. Approximately
200 ng of highly pure Cp. abortus DNAwas isolated
after measurement by UV-spectrometry (in a
Spectrophotometer DU 800). The approximate
number of genomic DNA templates per volume of
isolated DNA was calculated for use in our PCR
sensitivity test.
2.4.2. Spiking experiments
To assess the sensitivity of each PCR assay and to
account for potential inhibitory factors present in boar
semen, four spiking experiments using genomic DNA
of Cp. abortus S26/3 (as prepared in Section 2.4.1)
were performed. Ten-fold dilutions of chlamydial
genomic DNA (from 10,000 to 0.1 templates) in dH2O
and semen samples were performed as follows:
(i) 10-fold dilutions of Cp. abortus DNA in dH2O,
followed by DNA extraction with QIAamp DNA
kit (Qiagen) using the body fluid protocol as
described by the manufacturer;
(ii) 10-fold dilutions of Cp. abortus DNA in dH2O,
followed directly by PCR without DNA
extraction;
(iii) 10-fold dilutions of Cp. abortus DNA in
azoospermic semen (case No. 17), followed by
DNA extraction with QIAamp DNA kit (Qiagen)
as in (i);
(iv) 10-fold dilutions of Cp. abortus DNA in normal
sperm-count semen (case No. 8), followed by
DNA extraction as in (i) and (iii).
The products of DNA extraction from all dilution
series were tested and compared between all three
PCR assays: 16Sig, IGS-S and IGS-L PCRs.
2.5. Immunohistochemistry (IHC)
Paraffin sections from the genital organs of boars
(n = 41) were cut and screened for the presence of
chlamydial antigen using a Chlamydiaceae family
specific mouse monoclonal antibody (Ab) directed
against the chlamydial lipopolysaccharide (cLPS;
clone AC-1, Progen, Heidelberg, Germany) and the
streptavidin peroxidase method (DAKO, ChemateTM,
Glostrup, Denmark). Briefly, tissue sections were
deparaffinized, pretreated with 0.1% pronase for
10 min at room temperature (RT) and washed in
phosphate-buffered saline pH 8.0 (PBS). The sections
were immersed in a peroxidase blocking solution for
10 min at RT, washed in PBS and incubated with the
primary Ab (dilution 1:200 in Ab diluent, DAKO,
ChemMateTM) for 30 min at RT. Detection was
continued according to the manufacturer’s protocol.
Finally, the slides were developed using 3-amino-9-
ethyl-carbazole (AEC) substrate solution for 10 min at
RT, and counterstained with haematoxylin. Positive
control tissues are described elsewhere (Guscetti et al.,
2000).
2.6. Serological test
Twenty-three serum samples, collected from Swiss
boars (group A) prior to slaughtering, were examined
by ELISA using a method previously described (Knitz
et al., 2003). Briefly, microtiter plates were coated with
40 ng per well of antigen (LPS preparation fromEBs of
Cp. abortus strain OCLH196). Incubations with serum
dilutions (1:100) and horseradish peroxidase-conju-
gated goat anti-bovine IgG (H + L chain specific,
Sigma, Buchs, Switzerland) were performed for 1 h.
Antigen-antibody reactionswerevisualizedwithABTS
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(Roche, Rotkreuz, Switzerland) according to the
manufacturer’s recommendations. Optical densities
(OD) were measured at 405 nm by a computer-assisted
microplate reader (Tecan, Maennedorf, Switzerland).
Cut-off values were calculated for each microtiter plate
frommean OD values of seven negative serum samples
according to the method of Tijssen (1985).
2.7. Culture of non-chlamydial bacterial
contamination
Aliquots of semen samples (group A and B: n = 64)
and one piece of each genital organ (group A: n = 41)
were submitted for routine bacteriological examination.
2.8. Identification of species by DNA sequence
analysis
Chlamydial species identification was exclusively
done by direct DNA sequencing of PCR products.
Sequencing was performed in collaboration with the
sequencing service of the University of Zurich. The
obtained sequences were compared with sequences
available in GenBank using the BLAST server from
the National Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov/blast/).
3. Results
3.1. Sensitivity of PCR
Sensitivity results of the respective PCRs obtained
from our spiking experiments are summarised in
Table 2. Experiment (i) (dilutions of DNA in dH2O
with subsequent DNA extraction using a QIAamp
DNA kit) (Fig. 1, upper line) revealed an approximate
detection limit of 100, 10 and 10 templates with IGS-
Long, IGS-Short, and 16Sig PCRs, respectively. In
experiment (ii) (DNA diluted in dH2O followed
directly by PCR), the detection limits of IGS-Long and
IGS-Short were the same as in experiment (i), whereas
the 16Sig PCR detected one template (Fig. 1, lower
line). The spiking experiment (iii) performed with
azoospermic semen displayed a detection limit of
IGS-L, IGS-S, and 16Sig PCR at 100, 10 and 10
templates per ml of semen, respectively. The same
results were obtained in experiment (iv) which
involved dilution of Cp. abortus DNA in normal
sperm-count semen followed by DNA extraction
(Fig. 2). Based on these results, we selected 16Sig and
IGS-S PCR assays to test semen samples. Organ
samples were examined by IGS-S PCR method. The
examination of all genital organs and semen samples
using the IGS-S revealed negative results, suggesting
that the chlamydial burden was less than 10 templates.
3.2. Group A: chlamydial IHC detection in Swiss
boar genital organs
IHC for chlamydial antigen of genital organ
samples was negative in all animals.
3.3. Group A: serological results and chlamydial
DNA detection in Swiss boar semen
3.3.1. Serology (LPS-ELISA)
Three of 23 boars were positive using chlamydial
LPS-ELISA (Table 3).
3.3.2. 16Sig PCR
Three Swiss boar semen samples were positive
(12%, 3/25) for chlamydiae using the 16Sig PCR. One
sample (boar No. 2) was 98% identical to Cp. psittaci
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Table 2
Sensitivity of Chlamydia-specific PCRs tested in this study
Spiking experiments: dilution of Cp. abortus DNA in H2O/semen Detection limits of PCR assays
IGS-long
(templates/ml)
IGS-short
(templates/ml)
16Sig
(templates/ml)
i. DNA in H2O with DNA extraction
a 100 10 10
ii. DNA in H2O followed by PCR directly 100 10 1
iii. DNA in azoospermic semen with DNA extractiona 100 10 10
iv. DNA in normal sperm-count semen with DNA extractiona 100 10 10
a DNA extraction kit (Qiagen).
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(1/25, 4%), and two samples (2/25, 8%) shared 95 and
92% identity to uncultured Chlamydia-like organisms
in the order Chlamydiales (Nos. 6 and 21, respec-
tively). The comparison of PCR-positive cases with
other results is shown in Table 3.
3.4. Group B: 16Sig PCR detection of chlamydial
DNA in German boar semen
DNA of C. suis was detected in 10 of 39 semen
samples (25.6%) by 16Sig PCR (Table 4). DNA of a
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Fig. 1. Comparison of PCR sensitivity, tested on serial dilutions of Cp. abortus DNA in dH2O (dilutions from 10
4 to 10�1 templates).
Experiment (i) with DNA extraction (upper line), experiment (ii) without DNA extraction (lower line). The detection limits of three PCR assays:
IGS-L (lanes 1–6: 104 to 10�1 templates, respectively); IGS-S (lanes 7–12: 104 to 10�1 templates, respectively); 16S (lanes 13–18: 104 to 10�1
templates, respectively); lane M, molecular weight marker.
Fig. 2. Detection limits of threeChlamydia-specific PCR assays on boar semen (experiment (iv), dilutions ofCp. abortusDNA in normal sperm-
count semen): IGS-L (lanes 1–6: 104 to 10�1 templates, respectively); IGS-S (lanes 7–12: 104 to 10�1 templates, respectively); 16S (lanes 13–18:
104 to 10�1 templates, respectively); lane M, molecular weight marker.
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Chlamydia-like organism was detected in sample 78
(2.6%; 1/39) (93% identical to known strain). The
identity of C. suis specimens to known strain was 98%
in four cases, and 91–97% in six cases. Follow-up test
on semen from eight C. suis PCR-positive boars
(Table 4) were conducted 4 months after the initial
tests. DNA of C. suis could not be detected by PCR in
these samples, but one sample was newly positive for
Chlamydia-like organism (case No. 61). The positive
cases in group B were from three different AI centres
(AI1-3) as shown in Table 4.
3.5. Bacterial culture of semen and genital organ
samples
Bacteriology results of all semen samples (n = 64)
revealed only one sample positive forPseudomonas sp.
In the remaining semen samples, no specific bacteria
were isolated. Bacteriological examination of genital
organs revealed no specific bacteria in any cases.
4. Discussion
To investigate the prevalence of chlamydial
infections in semen and genital organs collected from
boars, we performed and compared three Chlamydia-
specific PCR assays targeting the 16S rRNA gene and
the flanking IGS. DNA dilution experiments revealed
that 16Sig and IGS-S Chlamydia-specific PCRs were
at least 10-fold more sensitive than the IGS-L PCR.
Spiking experiments using azoospermic and normal
sperm-count semen seemingly revealed the absence of
any potential PCR inhibitory factors in boar semen.
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Table 3
Summary of results from Swiss boars (group A) positive either by LPS-ELISA or 16Sig PCR
Case No. Age
(years)
Source
of boars
Serology
LPS-ELISA
16Sig PCR semen GenBank accession
No. (% identity)
IGS-S PCR
organs
2 2 AI � Cp. psittaci AB001814.1 (98%) �
6 1 AI � Uncultured
Chlamydiales
AY013443.1 (95%) �
20 5 AI + � � �
21 1 Natural
breeding
� Uncultured
Chlamydiales
AY013462.1 (92%) �
27 1 AI + na na �
29 5 AI + na na �
AI: artificial insemination; na: not available; (�): negative; (+): positive.
Table 4
Sources of positive boars in group B (Germany) and comparison between PCR results from the first ejaculates and the second ejaculates collected
4 months after the first collection
Case No. Source of boars 16Sig PCR semen Identity (%) GenBank accession No. 16Sig PCR of second ejaculates
50 AI-1 C. suis 91 U73110.2/CTU73110 –
54 AI-1 C. suis 94 U73110.2/CTU73110 na
55 AI-1 C. suis 98 U73110.2/CTU73110 –
60 AI-1 C. suis 97 U73110.2/CTU73110 –
61 AI-1 C. suis 98 U73110.2/CTU73110 Uncultured Chlamydiales GenBank
accession No. AY013468.1: 90% identity
62 AI-1 C. suis 94 U73110.2/CTU73110 –
63 AI-1 C. suis 98 U73110.2/CTU73110 –
64 AI-2 C. suis 98 U73110.2/CTU73110 –
69 AI-2 C. suis 96 U73110.2/CTU73110 na
74 AI-3 C. suis 91 U73110.2/CTU73110 –
78 AI-3 Uncultured
Chlamydiales
93 AY167120.1 na
AI: artificial insemination; na: not available; (�): negative.
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Based on these comparison experiments, 16Sig and
IGS-S PCR assays were used to test semen samples
collected from boars in group A (Switzerland) and
group B (Germany). Surprisingly, when compared to
the high prevalence of Chlamydia reported in semen
from boars in the recent Kauffold et al. (2006) study,
we found a relatively lower prevalence of Chlamydia
spp. in semen samples from both groups of boars. The
discrepancy of the results may be due to different
source of animals harbouring different disease
situations. Interestingly, and consistent with a number
of other recent studies investigating the prevalence of
Chlamydia in animal species (von Bomhard et al.,
2003; Camenisch et al., 2004), we were also able to
detect DNA sharing close similarity to a number of
Chlamydia-like organisms in boars from both groups.
In this study, we detected Cp. psittaci in one sample
originating from a 2-year-old boar in group A with
subfertility, however, Chlamydia was not detected
within genital organs. Since the presence ofCp. psittaci
DNA in semen disagreedwith the results obtained from
genital organ examination, the chlamydial infection
status is not clear whether this animal was probably just
a carrier shedding a very low number of bacteria. In
contrast to Cp. abortus which seems to be important in
reproductive diseases in pigs (Hoelzle et al., 2000;
Camenisch et al., 2004), the role of Cp. psittaci in
reproductive disorders of pigs is still unclear, although,
Cp. psittaci has been demonstrated in genital organs of
sows (Busch et al., 2000; Hotzel et al., 2004).
Of 39 ejaculates from Germany examined by 16Sig
PCR, we detected C. suis in 10 samples and
Chlamydia-like organisms in two samples. The
presence of C. suis DNA in semen may not indicate
an active infection in the genital tract, because
environmental contamination could not be completely
ruled out from the process of semen collection.
Among these C. suis-positive cases, PCR of second
ejaculates yielded negative result for C. suis. The
failure of C. suis detection in the second ejaculates
may be due to inapparent infection with intermittent
shedding of bacteria. To date, the significant role of C.
suis associated with reproductive failure is still
controversial. The presence of C. suisDNA in cervical
swabs was reported from both groups of sows, with
and without reproductive problems (Camenisch et al.,
2004). Nevertheless, C. suis was implicated as a cause
of abortions in sow (Schiller et al., 1997).
In the present study, we detected Chlamydia-like
organisms in four semen samples. TheChlamydia-like
organisms have been demonstrated in genital tracts of
sows with and without reproductive disorders (Came-
nisch et al., 2004). As previously discussed, a number
of recent reports have detected Chlamydia-like
organisms in clinical samples such as bovine placenta
(Borel et al., 2006) and conjunctival swabs from cats
(von Bomhard et al., 2003). However, the significance
of Chlamydia-like organisms in reproductive dis-
orders of animals remains to be elucidated. To our
knowledge, this is the first study demonstrating
Chlamydia-like organisms in semen of boars, and
further investigations regarding the importance of this
observation are warranted.
To further address the question of the chlamydial
disease state of boars in our study, we attempted to
detect the distribution of Chlamydia in the genital
organs available in group A. Considering the low
prevalence of chlamydial DNA in semen samples from
these animals, we were nonetheless surprised to find
that we were unable to detect the presence of
Chlamydia in 41 Swiss boars that were examined
by either IHC or IGS-S PCR. There was also no
correlation between serological positive cases and the
presence of chlamydial DNA in ejaculates or genital
organs. The positive serological results might be due
to Chlamydia infection in other organ systems or due
to a previous infection, not anymore detectable within
semen or male genital organs.
Taken all together, the presence of chlamydiae in
semen samples indicates the possibility of venereal
transmission of these pathogens to sows during mating
or AI, however, chlamydial infection in boars seems
not to play an important role in Switzerland.
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